(2000dec) Malignant gliomas,

(2002sep) Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis,

(2001apr) Anticancer drug resistance in primary human brain tumors,

(2002oct) The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma,

(2001mar) Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin,

(2001feb) Apoptosis in malignant brain tumor and application of chemotherapy,

(1994) 定志丸煎湯液이 實驗動物의 心血管系에 미치는 影響, 圓光大學校 大學院

(1996) 定志丸이 老化에 미치는 影響, 大田大學校 大學院

(1996) 定志丸이 腦組織의 生化學的 變化와 神經細胞의 損傷에 미치는 實驗的 硏究, 圓光大學校 大學院

(1997dec) Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms,

(1996oct) Human ICE/CED-3 protease nomenclature,

(1996apr) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis,

(2002apr) The use of temozolomide in recurrent malignant gliomas,

(1980) Cell death:the significance of apoptosis,

(1982) Necrosis and apoptosis:distinct modes of cell death with fundamentally different significance,

(2000) Apoptosis required for maintenance of homeostasis familial hemophagocytic lymphohistiocytosis caused by too little cell death,

(1994aug) Programmed cell death and the control of cell survival,

(1991) Programmed cell death:apoptosis and oncogenesis,

(2002) Irinotecan plus cisplatin in small-cell lung cancer,

(2002) Management of treatment-related toxicity in advanced ovarian cancer,

(2000) Clinical perspectives on platinum resistance,

(2002apr) Biomolecular targets for platinum antitumor drugs,

(1998) role of Bcl-2 and caspases,